Stock Taper 
SRZN
$22.42
▼ DOWN 6.62% (-1.59)
KEY STATISTICS
Market Cap$167.64 M
52w High$35.00
52w Low$11.25
Dividend Yield—
Frequency—
P/E-0.57
Volume239.36K
Shares Out.7.48M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Craig C. Parker
COMPENSATION 2026
Salary$630,000
Stock Awards$262,000
Incentive Plan Pay$346,500
All Other Comp.$0
Total$2,819,017
ABOUT
SECTOR
Healthcare
WENT PUBLIC
January 11, 2021
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
44
PRICE TARGET
Target High$44.00
Target Low$44.00
Target Median$44.00
Target Consensus$44.00
UPCOMING EARNINGS
DateNov 6, 2026
DayFriday
Rev. Est.$467.25K
NOV
6
FRI
SPLIT RECORD
| DATE | TYPE | RATIO |
|---|---|---|
| 2023-12-14 | Reverse | 1:15 |
PRICE
$22.42 ▼ DOWN 6.62% (−$1.59)About Surrozen, Inc.
https://www.surrozen.com ↗Surrozen, Inc. is a biotech firm developing tissue-specific antibodies to modulate the Wnt pathway for regenerative treatments across various organs and diseases.
INDUSTRY
Biotechnology
A PRODUCT SURROZEN, INC. IS KNOWN FOR
SZN-8141
SZN-8141 is Surrozen’s lead investigational bifunctional antibody targeting retinal diseases like wet AMD and DME, with an IND expected in 2026, reflecting the company's strategic focus on ophthalmology.
Revenue by Products
| Icon | PRODUCT | Q1-2026 | Q2-2026 |
|---|---|---|---|
 | Collaboration and license revenue | $5M | $5M |
Revenue by Geography
| Map | REGION | Q2-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
 | GERMANY | — | — | $5M | $5M |
 | UNITED STATES | $1M | $1.5M ▲ | — | — |
ETFS HOLDING THIS STOCK
ETFS HOLDING
41
LISTED HERE
7
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
100.00%
HOLDERS
74
TOP 12 OF 74 · RANKED BY POSITION SIZE
Consonance Capital Management LP
Tcg Crossover Management, LLC
Boxer Capital Management, LLC
Millennium Management LLC
Stempoint Capital LP
Vr Adviser, LLC
Ra Capital Management, L.P.
Braidwell LP
5am Venture Management, LLC
Vestal Point Capital, LP
Vanguard Group Inc
Vivo Capital, LLC
RATINGS SNAPSHOT
Overall rating: C+
Discounted Cash Flow3
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2
INSIDER TRADES
★
10 PERCENT OWNER
TCG Crossover GP II, LLC
Sale · 162.5K shares
2026-07-22
★
OFFICER: CHIEF FINANCIAL OFFICER
Maleki Andrew Pedrum
Purchase · 607 shares
2026-06-15
★
OFFICER: EXEC. VICE PRESIDENT, RESEARCH
Li Yang
Purchase · 1.7K shares
2026-06-15
★
OFFICER: CHIEF OPERATING OFFICER
Williams Charles O
Purchase · 1.7K shares
2026-06-15
MOST RECENT ANALYST GRADES
GRADE SUMMARY
BUY 1
OVERWEIGHT 1
2 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 IMMX | $13.94 | COMPARE |
 AGEN | $7.66 | COMPARE |
 IRD | $3.69 | COMPARE |
 GLSI | $15.67 | COMPARE |
 SEER | $1.98 | COMPARE |
 CGTX | $1.02 | COMPARE |
 TIL | $7.58 | COMPARE |
 TVGN | $6.89 | COMPARE |